Your prediction
Novozymes A/S B Stock
There is an upward development for Novozymes A/S B compared to yesterday, with an increase of €1.45 (2.950%).
Our community identified positive and negative aspects for Novozymes A/S B stock for the coming years. 1 users see the criterium "Return on equity" as a plus for the Novozymes A/S B stock. On the other hand our users think that "Revenue growth" could be a problem in the future.
Pros and Cons of Novozymes A/S B in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Novozymes A/S B vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Novozymes A/S B | 2.950% | -3.052% | -2.867% | -14.988% | -7.195% | 8.128% | -15.328% |
| Solvay S.A. A | -0.600% | -5.014% | -2.212% | -12.302% | -2.928% | -75.512% | -76.448% |
| Henkel AG & Co. KGaA VZO | -1.710% | 4.155% | -3.635% | -5.714% | -7.388% | -12.713% | -32.569% |
| Sherwin-Williams Co. | -1.140% | -1.933% | -6.535% | -14.635% | -2.713% | 28.109% | 13.892% |
